
VBI Vaccines Inc
OTC:VBIVQ

Fundamental Analysis


Revenue & Expenses Breakdown
VBI Vaccines Inc
Balance Sheet Decomposition
VBI Vaccines Inc
Current Assets | 26.4m |
Cash & Short-Term Investments | 12.6m |
Receivables | 1.7m |
Other Current Assets | 12m |
Non-Current Assets | 49.1m |
PP&E | 11m |
Intangibles | 36.8m |
Other Non-Current Assets | 1.2m |
Free Cash Flow Analysis
VBI Vaccines Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
VBI Vaccines Inc
Revenue
|
9.4m
USD
|
Cost of Revenue
|
-11.7m
USD
|
Gross Profit
|
-2.3m
USD
|
Operating Expenses
|
-69.9m
USD
|
Operating Income
|
-72.2m
USD
|
Other Expenses
|
-11.8m
USD
|
Net Income
|
-84m
USD
|
VBIVQ Profitability Score
Profitability Due Diligence
VBI Vaccines Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Score
VBI Vaccines Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.
VBIVQ Solvency Score
Solvency Due Diligence
VBI Vaccines Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Score
VBI Vaccines Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VBIVQ Price Targets Summary
VBI Vaccines Inc
Dividends
Current shareholder yield for VBIV is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?